A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours (Q33407051)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours |
scientific article |
Statements
1 reference
A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours (English)
1 reference
Jeffrey R Infante
1 reference
Kyriakos P Papadopoulos
1 reference
Johanna C Bendell
1 reference
Amita Patnaik
1 reference
Howard A Burris
1 reference
Drew Rasco
1 reference
Suzanne F Jones
1 reference
Lon Smith
1 reference
Donna S Cox
1 reference
Michael Durante
1 reference
Kevin M Bellew
1 reference
Joohyun Jennifer Park
1 reference
Ngocdiep T Le
1 reference
Anthony W Tolcher
1 reference
1 reference
Identifiers
1 reference